Literature DB >> 31289852

Suprasellar ganglioglioma presenting as a middle cerebral artery infarction.

Laura Pastor1,2, Sara Iglesias3, Bienvenido Ros3, Bernardo Weil4, María Isabel Martínez-León5, Miguel Ángel Arráez3.   

Abstract

BACKGROUND: Gangliogliomas are a relatively rare neoplasm with a major incidence in the pediatric population. As the temporal lobes are the most common site, patients usually present with seizures. CASE REPORT: We report the case of a 9-year-old child with an extensive suprasellar ganglioglioma presenting with a cerebral infarction due to direct compression of the medium cerebral artery.
CONCLUSIONS: Suprasellar lesions can compress adjacent vascular structures, so an accurate diagnosis is necessary for an early treatment.

Entities:  

Keywords:  BRAF V600E; Brain stroke; Ganglioglioma; Optic pathway; Suprasellar tumor

Year:  2019        PMID： 31289852     DOI： 10.1007/s00381-019-04292-z

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN： 0256-7040            Impact factor:   1.475


  17 in total

Review 1.  Ganglioglioma of the optic chiasm: case report and review of the literature.

Authors:  S Shuangshoti; E Kirsch; P Bannan; V A Fabian
Journal:  AJNR Am J Neuroradiol       Date:  2000-09       Impact factor: 3.825

2.  Intraventricular ganglioglioma with bleed: a rare case report.

Authors:  Dhananjaya I Bhat; Anita Mahadevan; Ranjan Manish; Somanna Sampath; B A Chandramouli; S K Shankar
Journal:  Neurol India       Date:  2010 May-Jun       Impact factor: 2.117

Review 3.  Pediatric sellar and suprasellar lesions.

Authors:  Jason W Schroeder; L Gilbert Vezina
Journal:  Pediatr Radiol       Date:  2011-01-26

4.  Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells.

Authors:  Christian Koelsche; Adelheid Wöhrer; Astrid Jeibmann; Jens Schittenhelm; Genevieve Schindler; Matthias Preusser; Felix Lasitschka; Andreas von Deimling; David Capper
Journal:  Acta Neuropathol       Date:  2013-02-24       Impact factor: 17.088

Review 5.  Pediatric infratentorial ganglioglioma.

Authors:  Stephanie Puget; Awad Alshehri; Kevin Beccaria; Thomas Blauwblomme; Giovanna Paternoster; Syril James; Federico Dirocco; Christelle Dufour; Michel Zerah; Pascale Varlet; Christian Sainte-Rose
Journal:  Childs Nerv Syst       Date:  2015-09-09       Impact factor: 1.475

6.  Isocitrate dehydrogenase 1 analysis differentiates gangliogliomas from infiltrative gliomas.

Authors:  Craig Horbinski; Julia Kofler; Gabrielle Yeaney; Sandra Camelo-Piragua; Sriram Venneti; David N Louis; Arie Perry; Geoffrey Murdoch; Marina Nikiforova
Journal:  Brain Pathol       Date:  2011-03-14       Impact factor: 6.508

7.  BRAF(V600E) mutation is a negative prognosticator in pediatric ganglioglioma.

Authors:  Sonika Dahiya; Devon H Haydon; David Alvarado; Christina A Gurnett; David H Gutmann; Jeffrey R Leonard
Journal:  Acta Neuropathol       Date:  2013-04-23       Impact factor: 17.088

8.  Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years.

Authors:  Cordelia Luyken; Ingmar Blümcke; Rolf Fimmers; Horst Urbach; Otmar D Wiestler; Johannes Schramm
Journal:  Cancer       Date:  2004-07-01       Impact factor: 6.860

9.  Successful treatment with dabrafenib (GSK2118436) in a patient with ganglioglioma.

Authors:  Kent C Shih; Mythili Shastry; Jeffrey T Williams; Peter F Jelsma; Steven R Abram; Kanyalakshmi Ayyanar; Howard A Burris; Jeffrey R Infante
Journal:  J Clin Oncol       Date:  2014-02-10       Impact factor: 44.544

10.  Ganglioglioma in the third ventricle: report on two cases.

Authors:  Tadahisa Shono; Masahiko Tosaka; Kenichi Matsumoto; Sadao Onaka; Shinya Yamaguchi; Masahiro Mizoguchi; Toru Iwaki; Yoichi Nakazato; Tomio Sasaki
Journal:  Neurosurg Rev       Date:  2007-05-10       Impact factor: 2.800
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.